The differential competence of various ITDs to bind and activate signal mediators might explain the prognostic difference of specific FLT3-ITD mutations in AML, and might also explain the superior prognosis of FLT3-TKD [50, 51]. Here, FLT3 is linked to acute myeloid leukemia.